ilShinbiobase Co. Ltd (068330) — Cash Flow-to-Debt Ratio
ilShinbiobase Co. Ltd (068330) has a Cash Flow-to-Debt Ratio of 0.47x as of March 2026, meaning its operating cash flow of ₩3.46 Billion could theoretically repay 0% of its total liabilities (₩7.33 Billion) in one year. Explore long-term investment intensity of ilShinbiobase Co. Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ilShinbiobase Co. Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for ilShinbiobase Co. Ltd across 12 annual periods. Also explore ilShinbiobase Co. Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year debt coverage analysis for ilShinbiobase Co. Ltd. For market capitalisation and broader financial context, see 068330 market cap.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.39x | ₩5.27 Billion | ₩3.79 Billion | ▲ +17.7% |
| 2024 | 1.18x | ₩4.12 Billion | ₩3.49 Billion | ▼ -29.2% |
| 2023 | 1.67x | ₩5.92 Billion | ₩3.55 Billion | ▲ +191.7% |
| 2022 | 0.57x | ₩2.65 Billion | ₩4.63 Billion | ▼ -46.1% |
| 2021 | 1.06x | ₩6.74 Billion | ₩6.36 Billion | ▲ +21.8% |
| 2020 | 0.87x | ₩4.50 Billion | ₩5.17 Billion | ▼ -14.2% |
| 2019 | 1.01x | ₩5.55 Billion | ₩5.47 Billion | ▼ -20.6% |
| 2018 | 1.28x | ₩4.88 Billion | ₩3.81 Billion | ▲ +97.7% |
| 2017 | 0.65x | ₩2.11 Billion | ₩3.27 Billion | ▲ +0.5% |
| 2016 | 0.64x | ₩3.01 Billion | ₩4.68 Billion | ▲ +1162.0% |
| 2015 | 0.05x | ₩270.22 Million | ₩5.30 Billion | ▼ -94.0% |
| 2014 | 0.85x | ₩3.33 Billion | ₩3.93 Billion | — |